It is announced today that CNS Network has purchased ALPHADAS®,
Logos Technologies Inc’s early phase, e-source data capture system and
site automation tools to accelerate and streamline its clinical trials.
ALPHADAS is to be implemented in their Orange County Research Center,
California, USA.
“Through the combination of this
automation and the recruitment abilities of CNS Network we believe that
we will have a significant advantage over other early phase research
organizations in our capacity to deliver clean, easily accessible,
timely data to sponsors.”
“We welcome CNS Network as our most recent client partner and look
forward to seeing them reap the tremendous rewards that ALPHADAS will
bring them” said Giles Wilson, BEng, CEO of Logos Technologies Inc.
“Providing real-time reporting and review to their clients and Sponsors
was an important requirement and through this partnership we look
forward to life changing and life saving drugs reaching the market
safely and more quickly.”